Date | Time | Place | Session / Title | Role |
April 29 | 7:00 AM - 8:10 AM | Room 104, Level 1 | DES & New BRS | Panelist |
April 29 | 7:32 AM - 7:40 AM | Room 104, Level 1 | DES & New BRS Is In-Stent Restenosis a Benign Event? |
Lecturer |
April 29 | 8:30 AM - 10:30 AM | Room 104, Level 1 | Left Main and Bifurcation PCI | Panelist |
April 29 | 8:38 AM - 8:46 AM | Room 104, Level 1 | Left Main and Bifurcation PCI Updated Meta-Analysis for PCI vs. CABG for Left Main Disease |
Lecturer |
April 29 | 10:30 AM - 12:25 PM | Room 104, Level 1 | DES & New BRS | Panelist |
April 29 | 11:25 AM - 11:33 AM | Room 104, Level 1 | DES & New BRS Updated Meta-Analysis of Bioresorbable Scaffolds: Sum Up Many, Many Meta for BRS |
Lecturer |
April 29 | 2:00 PM - 2:30 PM | Interview Lounge, Level 3 | DES & New BRS | Interviewee |
April 29 | 3:40 PM - 4:30 PM | Room 104, Level 1 | ACS & Pharmacotherapy | Panelist |
April 29 | 3:40 PM - 3:48 PM | Room 104, Level 1 | ACS & Pharmacotherapy DAPT Dilemmas in ACS: Where to Go - Shorter vs. Longer Durations? |
Lecturer |
April 30 | 7:00 AM - 8:00 AM | Room 105, Level 1 | Antithrombotic Therapy | Panelist |
April 30 | 7:00 AM - 7:12 AM | Room 105, Level 1 | Antithrombotic Therapy Ischemic and Bleeding Risk Prediction: Many Scores, Little Solutions |
Lecturer |
April 30 | 10:30 AM - 11:00 AM | Interview Lounge, Level 3 | Non-vitamin K antagonist Oral Anticoagulants(NOACs) in Atherosclerotic Cardiovascular Disease | Interviewee |
April 30 | 2:00 PM - 3:06 PM | Room 104, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary | Discussant |
April 30 | 2:51 PM - 2:55 PM | Room 104, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: Expanding Role of NOAC in PCI/AF, ACS, and Stable ASCVD: Recent Trials and Next Expectations |
Discussant |
April 30 | 4:56 PM - 5:51 PM | Room 104, Level 1 | TCTAP 2018 - Featured Clinical Research from Abstracts | Panelist |
April 30 | 5:47 PM - 5:51 PM | Room 104, Level 1 | TCTAP 2018 - Featured Clinical Research from Abstracts Discussion: A Prospective, Multi-center Registry to Assess the Novel Sirolimus-eluting Stent with Unique Fusion Coating for Coronary Revascularization in Real World Population: The en-ABL e-registry |
Discussant |
May 01 | 8:30 AM - 10:00 AM | Coronary Theater, Level 1 | Live Case & Lecture Session IV | Discussant |